ESC 365 - ICD indications in specific settings

EHRA Premium Access

ICD indications in specific settings

Event: EHRA 2018

Topic: Implantable Cardioverter / Defibrillator

Session type: Debate Session

Date: 18 March 2018

Time: 16:30 - 18:00

Session

12 presentations in this session

Opening question

Primary prevention in non-ischaemic cardiomyopathy - PRO

Speaker: Professor J. Nielsen (Aarhus N, DK)

Primary prevention in non-ischaemic cardiomyopathy - CON

Speaker: Professor J. Poole (Seattle, US)

Primary prevention in non-ischaemic cardiomyopathy - Rebuttal PRO

Primary prevention in non-ischaemic cardiomyopathy - Rebuttal CON

Chairperson conclusion & Closing question

Opening question

Ischaemic heart disease, LVEF>35% and stable ventricular tachycardia - PRO

Speaker: Associate Professor C. Israel (Bielefeld, DE)

Ischaemic heart disease, LVEF>35% and stable ventricular tachycardia - CON

Speaker: Professor C. Sticherling (Basel, CH)

Ischaemic heart disease, LVEF>35% and stable ventricular tachycardia - Rebuttal PRO.

4 speakers from this session

Professor Jens Cosedis Nielsen

Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus N (Denmark)

16 presentations

3 followers

Professor Jeanne Poole

University of Washington, Seattle (United States of America)

6 presentations

1 follower

Associate Professor Carsten W Israel

Bethel-Clinic, Bielefeld (Germany)

20 presentations

3 followers

Professor Christian Sticherling

University Hospital Basel, Basel (Switzerland)

11 presentations

0 follower

This platform is supported by